Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;49(11):2584-2592.
doi: 10.1111/jog.15767. Epub 2023 Aug 21.

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2020 and Annual Treatment Report for 2015

Kiyoshi Yoshino  1 , Tomoko Kurita  1 , Fumiaki Takahashi  2 , Satoru Nagase  3 ; Board members of the 2022 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology
Collaborators, Affiliations

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2020 and Annual Treatment Report for 2015

Kiyoshi Yoshino et al. J Obstet Gynaecol Res. 2023 Nov.

Abstract

Aim: To provide information including the trend of gynecological malignancies in Japan, we hereby present the annual patient report for 2020 and the Annual Treatment Report for 2015, on the outcomes of patients who started treatment in 2015.

Methods: The Japan Society of Obstetrics and Gynecology maintains an annual tumor registry, where information on gynecological malignancies from various participating institutions is gathered. The data of patients whose treatment with gynecologic malignancies was initiated in 2020 were analyzed retrospectively. Survival of the patients who started treatment with cervical, endometrial, and ovarian cancer in 2015 was analyzed by using the Kaplan-Meier, log-rank, and Wilcoxson tests.

Results: Treatment was initiated in 2020 for 7689 patients with cervical cancer, 13 113 with endometrial cancer, 8004 with ovarian, tubal, and peritoneal cancer, 2152 with ovarian borderline tumors, and with the others (260 vulvar cancer, 157 vaginal cancer, 464 uterine sarcoma, 50 uterine adenosarcoma, 136 trophoblastic diseases). This clinicopathological information was summarized as the patient annual report. The 5-year survival rates of the patients with cervical cancer were 92.3%, 76.2%, 56.5%, and 32.2% for Stages I, II, III, and IV, respectively. The 5-year survival rates for the patients with endometrial cancer were 93.9%, 87.6%, 71.4%, and 29.3% for Stages I, II, III, and IV, respectively. The 5-year survival rates for the patients with ovarian cancer (surface epithelial-stromal tumors) were 91.7%, 80.6%, 50.8%, and 39.7% for Stages I, II, III, and IV, respectively.

Conclusion: The annual tumor report is an important survey that provides knowledge on gynecological malignancy trends in Japan.

Keywords: Japan; annual report; cervical cancer; endometrial cancer; gynecologic cancer; ovarian; tubal and peritoneal cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

REFERENCES

    1. Nagase S. The patients annual report in 2020. Acta Obst Gynaec Jpn. 2022;74:2263-2345.
    1. Nagase S. The treatment annual report in 2015. Acta Obst Gynaec Jpn. 2022;74:2346-2406.
    1. Yoshino K, Kurita T, Takahashi F, Nagase S, Board members of the 2021 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014. J Obstet Gynaecol Res. 2022;48:1570-1579. https://doi.org/10.1111/jog.15284
    1. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895-1904. https://doi.org/10.1056/NEJMoa1806395
    1. American Cancer Society. Survival rate for cervical cancer, endometrial cancer, ovarian cancer. Cancer facts & figures. 2021. https://www.cancer.org/.